Next-Generation Onco-Therapeutics

Erscheinungsjahr 2026
ISBN: 978-0-443-44181-3
Verlag: Elsevier Science

Buch, Englisch, 588 Seiten, Format (B × H): 191 mm x 236 mm, Gewicht: 1179 g

Next-Generation Onco-Therapeutics explores the latest advancements in cancer treatment, focusing on personalized medicine and innovative therapeutic strategies. This book serves as a comprehensive resource for understanding how emerging technologies can reshape oncological care, providing insights into effective and compassionate patient management.
The content explores the cutting-edge developments in cancer therapies, featuring clinical examples and case studies that illustrate the practical application of new treatment modalities. It emphasizes the importance of integrative approaches that address the diverse needs of cancer patients, ensuring that healthcare professionals are equipped with the most current information in this rapidly evolving field.

Autoren/Hrsg.

Kumar, Awanish

Bondhopadhyay, Banashree

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

CHAPTER 1 Introduction to next-generation oncotherapeutics and evolution of cancer therapy
CHAPTER 2 Transforming cancer treatment through immunotherapy innovations
CHAPTER 3 Immune checkpoint inhibitors: mechanisms, efficacy, and challenges
CHAPTER 4 Targeted therapy advancements in tumor biology
CHAPTER 5 Psychosocial support and dietary regulations in cancer care
CHAPTER 6 Engineering microbes for cancer: advances in oncolytic microbial therapy
CHAPTER 7 Precision medicine in oncology treatments
CHAPTER 8 Gene engineering and editing in cancer therapeutics
CHAPTER 9 Integrative therapies and combination approaches for synergistic cancer therapeutics
CHAPTER 10 The importance of early detection and screening in cancer treatment
CHAPTER 11 Patient-centered care for cancer therapeutics
CHAPTER 12 Advances in cancer drug discovery integrated with computational approaches
CHAPTER 13 Technological advances in oncotherapeutics
CHAPTER 14 Ethics and accessibility in next generation cancer therapies
CHAPTER 15 Case studies and future prospects of next-generation onco-therapeutics

Über Autor(innen)

Kumar, Awanish
Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery.

Bondhopadhyay, Banashree
Dr. Banashree Bondhopadhyay is an Assistant Professor at the Centre for Medical Biotechnology, Amity University Uttar Pradesh, Noida, India. She earned her PhD from the University of Burdwan and completed her post-doctoral fellowship at ICMR-NICPR. Her research focuses on molecular oncology, with particular emphasis on breast cancer and hybrid anti-cancer natural products, and her work has appeared in journals including Biosensors and Bioelectronics and Cancers. She has over 17 SCI-indexed publications and is a recipient of the ICMR-DHR Women Scientist Fellowship and the Shri K.N. Narasimhiah Award.